Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Melatonin and Arsenic Trioxide

Research Papers that Mention the Interaction

Combined treatment with melatonin and ATO induced the phosphorylation of JNK and p38 MAP kinase downstream from Redd1 expression.
Interestingly, we found that the cell death induced by co-treatment with melatonin and ATO was mediated by sustained upregulation of Redd1, which was associated with increased production of reactive oxygen species (ROS).
Molecular and Cellular Endocrinology  •  2016  |  View Paper
Due to the safety profile of melatonin, our study suggests that using melatonin in combination with ATO might provide insight into a novel adjuvant therapy and may confer advantages for breast cancer treatment.
Our data highlighted for the first time that pre-treating MCF-7 cells with physiological concentration of melatonin substantially augmented the cytotoxic effects of ATO as compared with either agent alone.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2016  |  View Paper
Melatonin also improved the antioxidant enzymes SOD, GPX, and CAT activity induced by As2O3.
Oncotarget  •  2017  |  View Paper
Moreover, RQ-PCR analysis revealed that the enhanced cytotoxic effect of As2O3 in the presence of melatonin is mediated, at least partly, through suppressing the expression of NF-κB anti-apoptotic target genes such as MCL-1, BCL-2, survivin, XIAP, and c-IAP1 in breast cancer cells.
Noteworthy, an enhanced induction of apoptosis was found using As2O3 in combination with melatonin.
International journal of molecular and cellular medicine  •  2018  |  View Paper